FORMA Therapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
300 N Beacon St Ste 501, Watertown, Mass...Phone Number
(617) 679-1970Website
www.formatherapeutics.comRevenue
$56 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About FORMA Therapeutics
Founded in 2007, FORMA Therapeutics is a clinical-stage biopharmaceutical company that specializes in the development and research of hematologic diseases and cancers. FORMA Therapeutics is located in Massachusetts.Explore more
FORMA Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FORMA Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
FORMA Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at FORMA Therapeutics
Check if FORMA Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if FORMA Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if FORMA Therapeutics is spiking on competitors!
Earning: See what the market has to say on FORMA Therapeutics recently announced quarterly report
Product Launch: Get notified when FORMA Therapeutics launches new products
Funding: Get notified immidiatlly once FORMA Therapeutics has new funding data
Recommended Actions
Find VP level buyers at FORMA Therapeutics
Find 2 more new buyers
Compare Similar Companies to FORMA Therapeutics
Compare insights from companies similar to FORMA Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FORMA Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
FORMA Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about FORMA Therapeutics.
FORMA Therapeutics financials insights
Gather financial insights about FORMA Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Series A
$4M
2009
Series B
$25.5M
Private Equity
$3M
2012
Private Equity
$10M
Series C
$10M
2019
Series D
$100M
2020
Stock Offering
$319.3M
FORMA Therapeutics Tech Stack
A closer look at the technologies used by FORMA Therapeutics
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
FORMA Therapeutics News & Media
Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease
HANOVER, MD and WATERTOWN, Mass.--(BUSINESS WIRE)--Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the DiseaseThe M&A Class Action Firm Announces the Investigation of Forma Therapeutics Holdings, Inc. - FMTX
NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Forma Therapeutics Holdings, Inc. (FMTX), relating to its proposed acquisition by Novo Nordisk A/S. Under the terms of the tender offer, FMTXSHAREHOLDER ALERT: Weiss Law Investigates Forma Therapeutics Holdings, Inc.
NEW YORK, Sept. 1, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Forma Therapeutics Holdings, Inc. ("Forma Therapeutics" or the "Company") (NASDAQ: FMTX), in connection with the proposed...SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Forma Therapeutics Holdings, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - September 1, 2022) - Rigrodsky Law, P.A. is investigating Forma Therapeutics Holdings, Inc. ("Forma") (NasdaqGM: FMTX) regarding possible breaches of fiduciary duties and other violations of law related to Forma's agreement to be acquired by Novo Nordisk A/S. Under the terms of the agreement, Forma's shareholders will receive $20.00 per share.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-forma-therapeutics-ho
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FORMA Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2007, FORMA Therapeutics is a clinical-stage biopharmaceutical company that specializes in the development and research of hematologic diseases and cancers. FORMA Therapeutics is located in Massachusetts.... Read More
